Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community
Pharmacovigilance, the science and practice of monitoring the effects of medicinals and their safety, is the responsibility of all stakeholders involved in the development, manufacture, regulation, distribution, prescription, and use of drugs and devices. The patient is the stakeholder most impacted...
Saved in:
Main Authors: | Fiona Robinson (Author), Sonji Wilkes (Author), Nathan Schaefer (Author), Miriam Goldstein (Author), Michelle Rice (Author), Johanna Gray (Author), Sharon Meyers (Author), Leonard A. Valentino (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The MHRA pharmacovigilance inspection programme: priorities and challenges
by: Anna L Adams, et al.
Published: (2019) -
Clinical audit of inherited bleeding disorders in a developing country
by: Sajid Raihan, et al.
Published: (2010) -
Pharmacovigilance in Israel - tools, processes, and actions
by: Eyal Schwartzberg, et al.
Published: (2017) -
Educational Case: Autosomal Recessive Inheritance
by: D. Yitzchak Goldstein MD, et al.
Published: (2017) -
Protocols for Oral Health Management of Paediatric Patients with Inherited Bleeding Disorders: A Narrative Review
by: Ashleigh F. V. Raikuna, et al.
Published: (2023)